YourChoice Therapeutics Direct Investment Page

YourChoice Therapeutic's most recent presentation was at the 2025 Portfolia Annual Summit - Click Below to view the latest update:

YourChoice Therapeutics develops non-hormonal contraceptives designed to eliminate the risk of negative side effects associated with traditional hormonal contraceptives. The company's contraceptives work by blocking a protein in sperm required for fertilization, enabling customers to use safe birth control options with no side effects for men and women.

SPV Legal Entity Name and EINs:

Portfolia 2022 SPV 3 LLC (YourChoice SPV) | EIN: 88-2739443

Portfolia 2025 YourChoice SPV LLC | EIN 39-3161530

Portfolio Company | In the News

Supreme Court Dobbs Decision Has Contributed to Surge of Interest in Male Contraception
February 2, 2026

The Future of Male Birth Control Could Be Pills, Gels and Implants
February 4, 2026

Performance Overview

Quarterly Reports

The EOY highlights of 2025 updates as provided by the company. Please note all updates provided are confidential and not for distribution. To access the file, use password: EOY25YCSPV!

access the report